Recent Updates
Recently added Catalysts
KPTI

Karyopharm to Participate at Upcoming Investor Conferences

Key Takeaway: NEWTON, Mass., Nov. 8, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the following investor conferences i

Full Press Release Details

NEWTON, Mass., Nov. 8, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the following investor conferences in November:
Jefferies 2022 London Healthcare Conference
Format: Fireside chat
Date: Tuesday, November 15, 2022
Time: 3:35 a.m. ET / 8:35 a.m. GMT
Piper Sandler 34th Annual Healthcare Conference
Format: Podium presentation
Date: Tuesday, November 29, 2022
A live webcast of the presentation and fireside chat, along with accompanying slides, can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay for 90 days following each event.

About Karyopharm Therapeutics

XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.
SOURCE Karyopharm Therapeutics Inc.

21 %

more press release views with
Last updated: Nov 8, 2022